MJoTA (Medical Journal of Therapeutics Africa)

MiMW (MJoTA Institute of Medical Writing) - Emerald Pademelon Press LLC - MJoTA-NYEcho Partners

MJoTA Portal

Diabetes cinnamon rats

201205 Malaria bad drugs

201205MalariaDrugResistan

201205Malaria vaccine ph1

Diabetes cinnamon EJI

Diabetes cinnamon

Diabetes cinnamon lipids

Diabetes nutmeg

20120517 Coffee NEJM

20120517coffee alzheimers

20120517 Coffee Japan

20120104 NCHS twins

20120104 land of twins

20120194 Igbo twins

20120501 NIH asthma

20120501 Asthma US Africa

20120501 Asthma home

Dr Susanna website

Ganymede Movies LLP

Registration page

20111229 asd cdc

20111229 Autism video

20111229 MMWR

MJoTA.org resources 2011

Vaccinations

Diabetes

Diabetes CME resources

Diabetes Podcasts

Amer J Diabetes

Malaria

Malaria Podcasts

Liver

HIV/AIDS

HIV/AIDS Podcasts

BI HIV drug

CDC HIV

Cancer

Cancer Podcasts

Tuberculosis

Daily Updates

MiMW Certificate

MiMW

Calendar

MiMW Resources

MJoTAtalks: Health

MJoTA pages

Search page

MJoTA masthead

Author guidelines

MJoTA publications

Front covers

MJoTA 2011

MJoTA 2010

MJoTA 2009

MJoTA 2008

MJoTA 2007

MJoTA Mentors

homework Dec 09

MJoTA Presenting yourself

Job Fair

Regulatory doc files

Protocols

Indian drugs resources

Indian drug regulations

Kenya drug regs

Nigerian drug regs

Libya

Book concept to shelf

Health Audio Podcasts

Caribbean Health Podcasts

African Health Dialogues

African Health Podcasts

Child Health Podcasts

Contact us

Tropical diseases movies

 
Loading

Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.

Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Department of Neurology, University of Kuopio, P.O. Kuopio, Finland. J Alzheimers Dis. 2009;16(1):85-91.

Abstract: Caffeine stimulates central nervous system on a short term. However, the long-term impact of caffeine on cognition remains unclear. We aimed to study the association between coffee and/or tea consumption at midlife and dementia/Alzheimer's disease (AD) risk in late-life. Participants of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study were randomly selected from the survivors of a population-based cohorts previously surveyed within the North Karelia Project and the FINMONICA study in 1972, 1977, 1982 or 1987 (midlife visit). After an average follow-up of 21 years, 1409 individuals (71%) aged 65 to 79 completed the re-examination in 1998. A total of 61 cases were identified as demented (48 with AD). Coffee drinkers at midlife had lower risk of dementia and AD later in life compared with those drinking no or only little coffee adjusted for demographic, lifestyle and vascular factors, apolipoprotein E epsilon4 allele and depressive symptoms. The lowest risk (65% decreased) was found in people who drank 3-5 cups per day. Tea drinking was relatively uncommon and was not associated with dementia/AD. Coffee drinking at midlife is associated with a decreased risk of dementia/AD later in life. This finding might open possibilities for prevention of dementia/AD.

Download complete article as pdf, click here.


MJoTA.org. Published since 2006 by Emerald Pademelon Press LLC. PO Box 381 Haddonfield, NJ 08033, USA. 1-609-792-1571. Publisher@mjota.org